1. Home
  2. SVRA vs DNUT Comparison

SVRA vs DNUT Comparison

Compare SVRA & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • DNUT
  • Stock Information
  • Founded
  • SVRA 2007
  • DNUT 1937
  • Country
  • SVRA United States
  • DNUT United States
  • Employees
  • SVRA N/A
  • DNUT N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • DNUT Food Chains
  • Sector
  • SVRA Health Care
  • DNUT Consumer Staples
  • Exchange
  • SVRA Nasdaq
  • DNUT Nasdaq
  • Market Cap
  • SVRA 527.2M
  • DNUT 563.2M
  • IPO Year
  • SVRA N/A
  • DNUT 2021
  • Fundamental
  • Price
  • SVRA $3.95
  • DNUT $4.16
  • Analyst Decision
  • SVRA Buy
  • DNUT Buy
  • Analyst Count
  • SVRA 8
  • DNUT 6
  • Target Price
  • SVRA $6.88
  • DNUT $6.22
  • AVG Volume (30 Days)
  • SVRA 1.7M
  • DNUT 15.3M
  • Earning Date
  • SVRA 11-13-2025
  • DNUT 11-06-2025
  • Dividend Yield
  • SVRA N/A
  • DNUT 1.68%
  • EPS Growth
  • SVRA N/A
  • DNUT N/A
  • EPS
  • SVRA N/A
  • DNUT N/A
  • Revenue
  • SVRA N/A
  • DNUT $1,534,272,000.00
  • Revenue This Year
  • SVRA N/A
  • DNUT N/A
  • Revenue Next Year
  • SVRA N/A
  • DNUT $0.32
  • P/E Ratio
  • SVRA N/A
  • DNUT N/A
  • Revenue Growth
  • SVRA N/A
  • DNUT N/A
  • 52 Week Low
  • SVRA $1.89
  • DNUT $2.50
  • 52 Week High
  • SVRA $4.51
  • DNUT $12.27
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 50.44
  • DNUT 61.24
  • Support Level
  • SVRA $4.14
  • DNUT $3.46
  • Resistance Level
  • SVRA $4.51
  • DNUT $4.50
  • Average True Range (ATR)
  • SVRA 0.22
  • DNUT 0.43
  • MACD
  • SVRA -0.05
  • DNUT 0.02
  • Stochastic Oscillator
  • SVRA 11.63
  • DNUT 52.11

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

Share on Social Networks: